ContractStock Option Agreement • March 3rd, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • Delaware
Unless otherwise defined herein, the terms in the Stock Option Agreement (the “Option Agreement”) have the same meanings as defined in the 180 Life Sciences Corp. 2020 Omnibus Incentive Plan (as amended from time to time)(the “Plan”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 3rd, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (this “Agreement”) is made as of February 24, 2021, and effective November 6, 2020 (the “Effective Date”), between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and James N. Woody (“Executive”) (collectively, the Company and Executive are the “Parties”). This Agreement amends, supersedes, and replaces in its entirety that certain Employment Agreement between the Executive and 180 Life Corp. (formerly 180 Life Sciences Corp.), a Delaware corporation dated July 1, 2020, as amended from time to time (the “Prior Agreement”), effective as of the Effective Date.
EMPLOYMENT AGREEMENTEmployment Agreement • March 3rd, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • British Columbia
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into on the February 24, 2021, but to be effective for all purposes as of November 6, 2020 (the “Effective Date”), by and between KATEXCO PHARMACEUTICALS CORP., a British Columbia corporation (the “Company”), and OZAN PAMIR (“Executive”), an individual living at 788 Richards Street, Unit 2207, Vancouver, BC Canada V6B0C7. Certain capitalized terms used herein but not otherwise defined shall have the meanings as set forth in Section 16 of this Agreement.
CONSULTANCY AGREEMENTConsultancy Agreement • March 3rd, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • California
